RETREATMENT OF HCV DAA FAILURES: HCV INFECTION MAY BE INCURABLE

被引：4
|
作者：
Hezode, C. [1 ]
Fourati, S. [2 ]
Scoazec, G. [1 ]
Soulier, A. [2 ]
Varaut, A. [1 ]
Francois, M. [1 ]
Ruiz, I. [2 ]
Mallat, A. [1 ]
Chevaliez, S. [2 ]
Pawlotsky., J. -M. [2 ]
机构：
[1] Hop Henri Mondor, Hepatol, Creteil, France
[2] Hop Henri Mondor, Virol, Creteil, France
来源：
JOURNAL OF HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
10.1016/S0168-8278(16)00630-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-217
引用
收藏
页码：S400 / S400
页数：1
相关论文
共 50 条
  • [1] Retreatment Of HCV DAA Failures In Real Life: HCV Infection May Be Always Curable
    Ouzan, Denis
    Penaranda, Guillaume
    Le Folgoc, Gaelle
    Renou, Chris-Tophe
    Antoni, Michel
    Delasalle, Patrick
    Fontanges, Thierry
    Cerdan, Patricia
    Toulemonde, Pierre
    Beorchia, Sylvain
    Boyer, Nathalie
    Hanslik, Bertrand
    Halfon, Philippe
    Bourliere, Marc
    HEPATOLOGY, 2016, 64 : 448A - 449A
  • [2] Retreatment of HCV infection in DAA nonresponders
    Katrina Ray
    Nature Reviews Gastroenterology & Hepatology, 2015, 12 (5) : 252 - 252
  • [3] Retreatment of HCV Genotype 1 DAA-failures with Ombitasvir/Paritaprevir/r, Dasabuvir, and Sofosbuvir
    Poordad, Fred
    Bennett, Michael
    Sepe, Thomas E.
    Cohen, Eric
    Reindollar, Robert
    Everson, Gregory T.
    Phillips, Raymond W.
    Siddique, Asma
    Sullivan, Greg
    Box, Terry D.
    Fu, Bo
    Pilot-Matias, Tami
    Abunimeh, Manal
    Cohen, Daniel E.
    Younes, Ziad
    HEPATOLOGY, 2015, 62 (06) : 1392A - 1392A
  • [4] Telaprevir for Retreatment of HCV Infection
    Zeuzem, Stefan
    Andreone, Pietro
    Pol, Stanislas
    Lawitz, Eric
    Diago, Moises
    Roberts, Stuart
    Focaccia, Roberto
    Younossi, Zobair
    Foster, Graham R.
    Horban, Andrzej
    Ferenci, Peter
    Nevens, Frederik
    Muellhaupt, Beat
    Pockros, Paul
    Terg, Ruben
    Shouval, Daniel
    van Hoek, Bart
    Weiland, Ola
    Van Heeswijk, Rolf
    De Meyer, Sandra
    Luo, Don
    Boogaerts, Griet
    Polo, Ramon
    Picchio, Gaston
    Beumont, Maria
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (25): : 2417 - 2428
  • [5] Characteristics and retreatment of HCV DAA failure patients: Real-life experience
    Ruiz, I.
    Fourati, S.
    Varaut, A.
    Giovanna, S.
    Francois, M.
    Wlassow, M.
    Poiteau, L.
    Donati, F.
    Soulier, A.
    Stephane, C.
    Mallat, A.
    Pawlotsky, J. -M.
    Hezode, C.
    JOURNAL OF HEPATOLOGY, 2018, 68 : S277 - S278
  • [6] HCV resistance-associated substitutions in patients with HCV genotype 4 and failure to DAA combination therapies and implications for a retreatment
    Dietz, Julia
    Vermehren, Johannes
    Susser, Simone
    Peiffer, Kai-Henrik
    Welzel, Tania M.
    Mullhaupt, Beat
    Wursthorn, Karsten
    Petersen, Joerg
    Schattenberg, Jorn M.
    Chave, Jean-Philippe
    Niederau, Claus
    Schmid, Roland M.
    von Felden, Johann
    Julian, Schulze Zur Wiesch
    Moreno, Christophe
    von Hahn, Thomas
    Berg, Thomas
    Berg, Christoph P.
    Zeuzem, Stefan
    Sarrazin, Christoph
    HEPATOLOGY, 2017, 66 : 572A - 573A
  • [7] Prevalence of HCV infection in Europe in the DAA era: Review
    D'Ambrosio, Roberta
    Anolli, Maria P.
    Pugliese, Nicola
    Masetti, Chiara
    Aghemo, Alessio
    Lampertico, Pietro
    LIVER INTERNATIONAL, 2024, 44 (07) : 1548 - 1563
  • [8] Rare HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
    Dietz, Julia
    Graf, Christiana
    Berg, Christoph P.
    Port, Kerstin
    Deterding, Katja
    Buggisch, Peter
    Peiffer, Kai-Henrik
    Vermehren, Johannes
    Dultz, Georg
    Geier, Andreas
    Reiter, Florian P.
    Bruns, Tony
    Schattenberg, Joern M.
    Durmashkina, Elena
    Gustot, Thierry
    Moreno, Christophe
    Trauth, Janina
    Discher, Thomas
    Fischer, Janett
    Berg, Thomas
    Kremer, Andreas E.
    Muellhaupt, Beat
    Zeuzem, Stefan
    Sarrazin, Christoph
    JHEP REPORTS, 2024, 6 (07)
  • [9] Telaprevir for retreatment of HCV infection: review of the REALIZE trial
    Kim, Edward
    Chen, Yuan
    Yoshida, Eric M.
    FUTURE VIROLOGY, 2012, 7 (05) : 435 - 440
  • [10] Unusual HCV subtypes and retreatment outcomes in a cohort of European DAA-experienced patients
    Dietz, Julia
    Graf, Christiana
    Berg, Christoph P.
    Port, Kerstin
    Deterding, Katja
    Buggisch, Peter
    Vermehren, Johannes
    Dultz, Georg
    Peiffer, Kai-Henrik
    Geier, Andreas
    Bruns, Tony
    Moreno, Christophe
    Trauth, Janina
    Discher, Thomas
    Berg, Thomas
    Kremer, Andreas E.
    Muellhaupt, Beat
    Zeuzem, Stefan
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2023, 78 : S96 - S96
12345